Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Denali Therapeutics Inc. | 216,585 | reported | 13 Aug 2025 | tx 210+1,694,621−793,480 |
| Beam Therapeutics Inc. | 33,662 | reported | 04 Jun 2025 | tx 5+90,576 |
| Royalty Pharma plc | 8,558 | reported | 31 Jul 2025 | tx 2+8,558 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 8+161,763−161,763 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Aug 2025 | SALE | Denali Therapeutics Inc. | 806 | 14.64 USD | |
| 12 Aug 2025 | SALE | Denali Therapeutics Inc. | 2,937 | 13.58 USD | |
| 05 Aug 2025 | EXERCISE | Denali Therapeutics Inc. | 44,655 | 0.68 USD | |
| 05 Aug 2025 | EXERCISE | Denali Therapeutics Inc. | 44,655 | 0.00 USD | deriv |
| 31 Jul 2025 | GRANT_AWARD | Royalty Pharma plc | 5,806 | 0.00 USD | |
| 31 Jul 2025 | GRANT_AWARD | Royalty Pharma plc | 2,752 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Beam Therapeutics Inc. | 33,662 | 0.00 USD | deriv |
| 06 Jan 2025 | SALE | Denali Therapeutics Inc. | 12,255 | 20.22 USD | |
| 07 Jan 2025 | SALE | Denali Therapeutics Inc. | 2,907 | 20.81 USD | |
| 03 Jan 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 54,180 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 162,540 | 0.00 USD | deriv |
| 25 Nov 2024 | EXERCISE | Denali Therapeutics Inc. | 17,845 | 0.68 USD | |
| 25 Nov 2024 | EXERCISE | Denali Therapeutics Inc. | 17,845 | 0.00 USD | deriv |
| 20 Aug 2024 | SALE | Denali Therapeutics Inc. | 2,453 | 23.79 USD | |
| 21 Aug 2024 | SALE | Denali Therapeutics Inc. | 14,098 | 24.41 USD | |
| 21 Aug 2024 | SALE | Denali Therapeutics Inc. | 5,907 | 24.96 USD | |
| 13 Aug 2024 | SALE | Denali Therapeutics Inc. | 2,337 | 22.89 USD | |
| 05 Jun 2024 | GRANT_AWARD | Beam Therapeutics Inc. | 23,114 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 78,407 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 24,222 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 19,619 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 39,515 | — | deriv |
| 13 Feb 2024 | SALE | Denali Therapeutics Inc. | 2,784 | 17.29 USD | |
| 14 Feb 2024 | SALE | Denali Therapeutics Inc. | 1,405 | 17.79 USD | |
| 10 Jan 2024 | SALE | Denali Therapeutics Inc. | 4,668 | 19.02 USD |